{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:41:19Z","timestamp":1791268879163,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180886"],"award-info":[{"award-number":["U10CA180886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180899"],"award-info":[{"award-number":["U10CA180899"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijrobp.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:05:25Z","timestamp":1763827525000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children\u2019s Oncology Group"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2482-594X","authenticated-orcid":false,"given":"Safia K.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odion","family":"Binitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Krailo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Indelicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra K.","family":"Callan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"DelRocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Lor","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Nadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Pawel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon R.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Gorlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Janeway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Leavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N.I.","family":"Laack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.11.010_bib0001","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/pbc.21618","article-title":"Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children\u2019s Oncology Group","volume":"51","author":"Leavey","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0002","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1200\/JCO.2005.05.105","article-title":"Survival after recurrence of Ewing\u2019s sarcoma family of tumors","volume":"23","author":"Barker","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0003","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/COC.0b013e318281d6ab","article-title":"Clinical outcomes of adult patients with relapsed Ewing sarcoma: A 30-year single-institution experience","volume":"37","author":"Robinson","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pbc.23040","article-title":"Risk of recurrence and survival after relapse in patients with Ewing sarcoma","volume":"57","author":"Stahl","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/CORR.0000000000000962","article-title":"Which factors are associated with local control and survival of patients with localized pelvic Ewing\u2019s sarcoma? A retrospective analysis of data from the Euro-EWING99 trial","volume":"478","author":"Andreou","year":"2020","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0007","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2017.08.020","article-title":"Identification of patients with localized Ewing sarcoma at higher risk for local failure: A report from the Children\u2019s Oncology Group","volume":"99","author":"Ahmed","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/681425","article-title":"Adult Ewing sarcoma: Survival and local control outcomes in 102 patients with localized disease","volume":"2013","author":"Ahmed","year":"2013","journal-title":"Sarcoma"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0009","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/02841860500519760","article-title":"Prognostic factors in non-metastatic Ewing\u2019s sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998","volume":"45","author":"Bacci","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2014.11.023","article-title":"Ewing sarcoma in adults treated with modern radiotherapy techniques","volume":"113","author":"Casey","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0360-3016(02)03797-5","article-title":"Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials","volume":"55","author":"Schuck","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0012","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2006.05.9188","article-title":"Local control in pelvic Ewing sarcoma: Analysis from INT-0091\u2013A report from the Children\u2019s Oncology Group","volume":"24","author":"Yock","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijrobp.2022.02.011","article-title":"Modern therapy for chest wall Ewing sarcoma: An update of the University of Florida experience","volume":"113","author":"Indelicato","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2022.01.007","article-title":"Modern therapy for spinal and paraspinal Ewing sarcoma: An update of the University of Florida experience","volume":"113","author":"Indelicato","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0015","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijrobp.2005.07.299","article-title":"Radiation therapy for Ewing\u2019s sarcoma: Results from Memorial Sloan-Kettering in the modern era","volume":"64","author":"La","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113260","article-title":"Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing sarcoma. Report from the Ewing 2008 trial","volume":"192","author":"Heesen","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0017","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing\u2019s sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0018","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.21.00358","article-title":"Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic Ewing sarcoma: A Children\u2019s Oncology Group report","volume":"39","author":"Leavey","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31820","article-title":"Preoperative radiotherapy in patients with localized Ewing sarcoma enrolled on AEWS1031: A report from the Children\u2019s Oncology Group","volume":"72","author":"Indelicato","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.29065","article-title":"Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children\u2019s Oncology Group","volume":"121","author":"DuBois","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0021","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1200\/JCO.23.00053","article-title":"Long-term outcomes in patients with localized ewing sarcoma treated with interval-compressed chemotherapy on Children\u2019s Oncology Group study AEWS0031","volume":"41","author":"Cash","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0022","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1200\/JCO.2000.18.17.3108","article-title":"Prognostic factors in Ewing\u2019s tumor of bone: Analysis of 975 patients from the European intergroup cooperative Ewing\u2019s sarcoma study group","volume":"18","author":"Cotterill","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26504","article-title":"Pelvis Ewing sarcoma: Local control and survival in the modern era","volume":"64","author":"Ahmed","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0024","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00043426-200302000-00007","article-title":"Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis","volume":"25","author":"Bacci","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijrobp.2008.02.023","article-title":"Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity","volume":"72","author":"Indelicato","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0026","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/pbc.25710","article-title":"Patient-reported functional and quality of life outcomes in a large cohort of long-term survivors of Ewing sarcoma","volume":"62","author":"Stish","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0027","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2022.04.024","article-title":"Radiation therapy dose escalation in unresectable Ewing sarcoma: Final results of a phase 3 randomized controlled trial","volume":"113","author":"Laskar","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.11.010_bib0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2016.04.001","article-title":"Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control","volume":"96","author":"Talleur","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625064764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625064764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:17:32Z","timestamp":1780388252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625064764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0360301625064764"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.11.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children\u2019s Oncology Group","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}